CINECA IRIS Institutional Research Information System

Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial

PALUMBO, Antonio;
2015-01-01
2015
15
9
519
530
http://www.sciencedirect.com/science/journal/21522650
Low dose dexamethasone; Multiple myeloma; Pomalidomide; Quality of life; Relapsed/Refractory; Cancer Research; Hematology; Oncology
Weisel, Katja; Dimopoulos, Meletios; Song, Kevin W.; Moreau, Philippe; Palumbo, Antonio; Belch, Andrew; Schey, Stephen; Sonneveld, Pieter; Sternas, Lars; Yu, Xin; Amatya, Ramesh; Gibson, Craig J.; Zaki, Mohamed; Jacques, Christian; San Miguel, Jesus
03A-Articolo su Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1526950
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 41
social impact